In its initial phase, the collaboration has the potential to establish Oxford Nanopore’s information-rich, real-time sequencing technology across A.D.A.M. Innovations’ advanced genetic testing portfolio, enabling rapid and precise genomic testing across multiple disease areas.

The goal of the collaboration is to introduce new clinical workflows under Japan-specific validation standards to support scalable sequencing of DNA fragments of any length for various conditions and diseases. Sequencing that captures complete genomic information will expand testing accuracy beyond what can be achieved through existing technologies.